Paradigm Biocapital Advisors LP - GLOBAL BLOOD THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$80,077,000
+73.4%
1,175,879
-18.7%
10.68%
+15.9%
Q2 2022$46,186,000
+37.9%
1,445,566
+49.5%
9.21%
+4.0%
Q1 2022$33,491,000
+46.6%
966,827
+23.9%
8.86%
+35.7%
Q4 2021$22,845,000–780,480–6.52%–
 Download
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders